Target intelligence / Profile preview

Annexin A13 (ANXA13)

Target
ANXA13
Molecular classification
Calcium-dependent phospholipid-binding protein, Other (Annexin family; not a receptor, enzyme, channel, or transporter)
01

Overview

Annexin A13 is a calcium-dependent phospholipid-binding protein, primarily expressed in intestinal and kidney epithelial cells, especially in proliferating crypt epithelia and differentiated villus enterocytes[1][2][3][4]. Alternative splicing leads to distinct isoforms with differing subcellular localizations and membrane-binding requirements. The protein is localized to plasma membranes, specifically participating in apical transport in polarized cells — notably the apical region of villi in the intestine[1][2][3][5]. It is the most ancestral member ("founder gene") of the vertebrate annexin family, and may be implicated in raft-mediated delivery of membrane proteins, vesicle trafficking, and cellular differentiation, but its specific in vivo functions remain only partially understood[1][2][3][5]. There are no current drugs or biomarker uses involving annexin A13, and it is not established as a therapeutic target.

Other names
Annexin A13ANXA13ANX13ISAAnnexin XIIIAnnexin-13Intestine-specific annexin
02

Biological functions

Cellular growth regulationSignal transductionIntracellular transport (especially lipid raft-mediated delivery of apical proteins)Membrane fusion and trafficking in polarized epithelial cells (especially apical and basolateral transport)Potential involvement in calcium signal transduction, endo- and exocytosis
03

Disease associations

Limited associations; reported in Non-suppurative otitis media and Trichorhinophalangeal syndrome type II (not major disease targets)Other (no strong evidence as a major disease driver or drug target)

Beyond the preview

Go deeper on Annexin A13 (ANXA13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Annexin A13 (ANXA13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call